ReviewClinical cardiology2020
Transcatheter aortic valve replacement over age 90: Risks vs benefits.
Review in Clinical cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 14 citations in OpenAlex.
- Integrating frailty and acute illness severity scoring for risk stratification in acute geriatric care: Review and practical guide.World journal of critical care medicine · 2026Review
- Minimally Invasive Aortic Valve Replacement in Elderly Patients: Insights from a Large Cohort.Journal of clinical medicine · 2026Article
- From symptoms to strategy: pre-procedural NYHA-class as a key to risk stratification and personalized TAVR-management.Frontiers in cardiovascular medicine · 2026Article
- Outcome of Nonagenarians Undergoing Transfemoral Transcatheter Aortic Valve Replacement: A Nationwide Registry Analysis From Japan.JACC. Asia · 2022Article
- A Case of Transcatheter Aortic Valve Implantation in a Centenarian Patient.Case reports in cardiology · 2021Article
- Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients.Frontiers in endocrinology · 2021Article
- Restricted mean survival time of older adults with severe aortic stenosis referred for transcatheter aortic valve replacement.BMC cardiovascular disorders · 2020Article
- Transcatheter aortic valve replacement over age 90: Risks vs benefits.Clinical cardiology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the population ages, clinicians will encounter a growing number of nonagenarians suffering from severe aortic stenosis who may be candidates for transcatheter aortic valve replacement (TAVR). By virtue of a healthy survivor effect or a referral bias, these patients may paradoxically have greater resilience and fewer comorbidities than their octogenarian counterparts. They tend to, on average, tolerate the TAVR procedure quite well with low in-hospital and 1-year mortality rates of 5.5% and 23%, respectively. Appropriate patient selection should consider individualized estimates of procedural risk, potential for functional recovery and for improved quantity and quality of life. Frailty is much more revealing than chronological age, and it can be measured by brief tools such as the Essential Frailty Toolset. Ultimately, the process of shared decision-making is paramount to ensure that the course of action is patient-centered and balances the procedure's expected risks and benefits with the nonagenarian's preferences and values.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.